Pharma-Bio Serv, Inc. (PBSV) is a publicly traded company in the Unknown sector. Across all available filings, 9 corporate insiders have executed 150 transactions totaling $2.1M, demonstrating a bearish sentiment with -$1.1M in net insider flow. The most recent transaction on Jan 10, 2026 involved a transaction of 20,000 shares valued at $0.
No significant insider buying has been recorded for PBSV in the recent period.
No significant insider selling has been recorded for PBSV in the recent period.
Based on recent SEC filings, insider sentiment for PBSV is bearish with an Insider Alignment Score of 24/100 and a net flow of -$1.1M. Insiders are reducing their positions, though this can be driven by factors unrelated to company outlook.
Insider trading at Pharma-Bio Serv, Inc. (PBSV) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 9 insiders are actively trading PBSV stock, having executed 150 transactions in the past 90 days. The most active insider is Partners Lp Barron (Executive), who has made 18 transactions totaling $1.3M.
Get notified when executives and directors at PBSV file new Form 4 transactions
Date | Insider | Title | Type | Shares | Price | Value | Flags |
|---|---|---|---|---|---|---|---|
| Jan 10, 2026 | L. Wiesen Irving | Executive | Award | 20,000 | $N/A | $0 | |
| Jan 10, 2026 | Spindel Howard | Executive | Award | 20,000 | $N/A | $0 | |
| Jan 10, 2026 | Perlysky Dov | Executive | Award | 20,000 | $N/A | $0 | |
| Jan 10, 2026 | Wheeler Michel Kirk | Executive | Award | 20,000 | $N/A | $0 | |
| Jan 5, 2024 | Spindel Howard | Executive | Option Exercise | 20,000 | $1.00 | $20.0K | |
| Jan 5, 2024 | Spindel Howard | Executive | Gift | 1,132 | $N/A | $0 | |
| Jan 5, 2024 | Spindel Howard | Executive | Payment | 18,868 | $1.06 | $20.0K | |
| Jan 5, 2024 | Spindel Howard | Executive | Gift | 1,132 | $N/A | $0 | |
| Jan 5, 2024 | Wheeler Michel Kirk | Executive | Option Exercise | 20,000 | $0.76 | $15.2K | |
| Jan 5, 2024 | Wheeler Michel Kirk | Executive | Payment | 14,340 | $1.06 | $15.2K | |
| Mar 24, 2023 | Perlysky Dov | Executive | Option Exercise | 20,000 | $0.76 | $15.2K | |
| Mar 24, 2023 | Perlysky Dov | Executive | Option Exercise | 20,000 | $1.00 | $20.0K | |
| Mar 24, 2023 | Perlysky Dov | Executive | Payment | 12,991 | $1.17 | $15.2K | |
| Mar 24, 2023 | Perlysky Dov | Executive | Payment | 17,094 | $1.17 | $20.0K | |
| Mar 24, 2023 | L. Wiesen Irving | Executive | Option Exercise | 20,000 | $0.76 | $15.2K |
| TYPE | COUNT | VALUE | % |
|---|---|---|---|
Sale(S) | 21 | $1.6M | 33.6% |
Exercise(M) | 51 | $1.1M | 22.6% |
Payment(F) | 46 | $1.1M | 22.4% |
Purchase(P) | 4 | $508.7K | 10.6% |
Award(A) | 5 | $340.7K | 7.1% |
Exercise (Options)(X) | 2 | $110.9K | 2.3% |
Disposition(D) | 1 | $63.0K | 1.3% |
Gift(G) | 16 | $0 | 0.0% |
Other(J) | 3 | $0 | 0.0% |
Conversion(C) | 1 | $0 | 0.0% |
Insider selling pressure at Pharma-Bio Serv, Inc. has increased, with 9 insiders executing 150 transactions across all time. Total sales of $1.6M significantly outpace purchases of $508.7K, resulting in a net outflow of $1.1M. This selling activity appears largely discretionary, which may warrant closer attention from investors.